Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...

Proposals to eliminate the self-affirmed GRAS pathway have sent shockwaves through the food industry. But what do they mean ...

Fintel reports that on March 18, 2025, RBC Capital initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform ...

Billionaire Elon Musk, who heads Trump's Department of Government Efficiency (DOGE), is also a Diet Coke fan, has also made ...

This press release aims to clarify what Arialief is, how it works, and why so many people are asking questions like "Is ...

Which restaurants use beef tallow? Is it a better alternative to seed oil? Why did McDonald's stop using tallow, aka beef ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

No change in the last quarter ... 0.4 mg for intracanalicular use, is FDA-approved for the treatment of ocular inflammation ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

In this analysis presented at the American Academy of Dermatology annual meeting, serious adverse events were low, unrelated ...